Research & Development



  于是命丞相蕭何參照《秦律》制定漢律。   曹襄對甦稚的大手大腳依舊很不滿。大香蕉在线影院   於單一個骨碌從查罕的懷里滾出來,連滾帶爬的來到何愁有的跟前,抱著何愁有的腿道︰“救我!”伊人大香蕉   這里是魔怪的獵場。   沒人去管那些已經失去了戰斗力的人,他們繞開那堆七扭八歪的肉堆,向任何還坐在馬上的人發起進攻。伊人大香蕉久久网 第九十四章 好事當前又遠遁千里

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo